Feature

COVID-19 vaccination rate rising quickly among adolescents


 

With nearly half of all Americans having received at least one dose of a COVID-19 vaccine, the youngest eligible group is beginning to overcome its late start, according to data from the Centers for Disease Control and Prevention.

Proportion of children with at least one vaccine dose by age group

As of May 24, 49.4% of the U.S. population – that’s almost 164 million people – has received at least one dose of vaccine. The corresponding figure for children aged 12-15 years is 14.4%, but that’s up from only 0.6% just 3 weeks before. Among children aged 16-17, who’ve been getting vaccinated since early April in some states, the proportion receiving at least one dose went from 24.9% to 33.9% over those same 3 weeks, the CDC said on its COVID Data Tracker site.

The comparatively rapid increase among the younger group of eligible children can be seen over the last 14 days. The 12- to 15-year-old group represents 21.3% of all the vaccines initiated in the 2-week period ending May 24, compared with 4.2% for those aged 16-17, the CDC data show. To put that into perspective, only those aged 25-39 years were higher at 21.9%, while 18-24 (12.1%), 40-49 (13.4%), 50-64 (18.2%), 65-74 (5.3%), and ≥75 (2.9%) were all lower.

The 12- to 15-year-olds are further behind when it comes to full vaccination status, however, with just 0.6% having received both doses of a two-dose vaccine or one dose of the single-shot variety, compared with 21.6% for those aged 16-17 years. Children aged 12-15 make up 5% of the total U.S. population but just 0.1% of all those who have been fully vaccinated versus 2.5% and 1.4%, respectively, for those aged 16-17, the CDC reported.

Recommended Reading

Patients with CLL have significantly reduced response to COVID-19 vaccine 
MDedge Infectious Disease
Omics analysis links blood type to COVID-19
MDedge Infectious Disease
Dr. Fauci: Extraordinary challenges, scientific triumphs with COVID-19
MDedge Infectious Disease
COVID-19 in children: Weekly cases drop to 6-month low
MDedge Infectious Disease
New guidance for those fully vaccinated against COVID-19
MDedge Infectious Disease
Atorvastatin: A potential treatment in COVID-19?
MDedge Infectious Disease
Worse outcomes for patients with COPD and COVID-19
MDedge Infectious Disease
A new take on breathing and a performance-enhancing placebo
MDedge Infectious Disease
ID experts dole out practical advice to help with mask confusion
MDedge Infectious Disease
Dengue may double the risk of symptomatic COVID-19
MDedge Infectious Disease